3d
MedPage Today on MSNFor Your Patients: What Is Multiple Myeloma?Although the cause of multiple myeloma is not known, research shows that genetic changes in the DNA of a single plasma cell ...
Follow along on our guide to Multiple Myeloma, a cancer of the bone marrow's infection-fighting plasma cells. As cancerous ...
An elderly patient who was initially suspected of having antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) was instead diagnosed with multiple myeloma, according to a case report ...
After being diagnosed with multiple myeloma, Valarie Traynham turned her journey into a mission—raising awareness, educating ...
Multiple myeloma (MM) is a blood cancer that affects plasma cells in bone marrow. It’s a particularly insidious form of ...
2d
GlobalData on MSNHealthTree introduces AI-powered tool to match myeloma patients with trialsThe HealthTree Foundation has announced the launch of the new artificial intelligence (AI)-powered personalised Clinical ...
Study reveals multiple high-risk genetic changes predict worse multiple myeloma outcomes across all treatments.
Alfred L. Garfall, MD, discusses the phase 2 BMT CTN 1902 trial of idecabtagene vicleucel in patients with multiple myeloma.
Patients with RA who have used b/tsDMARDs demonstrated similar risks for multiple myeloma when compared with those taking only csDMARDs.
Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Multiple myeloma is a rare blood cancer of the plasma cells in bone marrow -- the soft, spongy interior of bone where ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results